Vitiligo Therapeutic Assessment Analysis Report 2024: Comprehensive Insights About 20+ Companies and 20+ Pipeline Drugs Featuring Key Players - AbbVie, Pfizer, Incyte, Ahammune Biosciences, & Amgen
Most Shorted S&P 500 Stocks in June
Is Incyte Corporation's (NASDAQ:INCY) Recent Stock Performance Tethered To Its Strong Fundamentals?
Incyte, Moderna Among Most Shorted S&P 500 Healthcare Stocks in June
Is Incyte Corporation's (NASDAQ:INCY) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Incyte (NASDAQ:INCY) has had a great run on the share market with its stock up by a significant 21% over the last three months. Given that the market rewards strong financials in the long-term, we
Goldman Sachs Adjusts Price Target on Incyte to $61 From $60, Maintains Neutral Rating
Incyte (INCY) has an average outperform rating and a price target range of $48 to $88, according to analysts polled by Capital IQ.
Express News | Incyte Corp : JP Morgan Cuts Target Price to $59 From $60
Incyte (INCY) Gains 19.6% in Three Months: Here's Why
Form 144 | Incyte(INCY.US) Officer Proposes to Sell 488.88K in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 9, $Incyte(INCY.US)$ Officer BARRY FLANNELLY intends to sell 8,148 shares of its common stock on Jul 9, with a total market value of approximately $488.88K. BARRY
S&P 500, Nasdaq Set New Closing Records After Fed Chair Powell's Comments
The S&P 500 and the Nasdaq Composite closed at new record highs Tuesday after Federal Reserve Chair Jerome Powell said inflation seems to have improved in recent months, though the job is not done
S&P 500 Hits Record Highs, Eyes 6th Straight Gain As Powell Keeps Bears At Bay; Tesla Targets 10th Consecutive Win, Bank Stocks Rally: What's Driving Markets Tuesday?
The S&P 500 index climbed to new all-time highs, rising 0.3% during Tuesday's session, aiming for a potential sixth consecutive positive close and remaining resilient after Fed Chair Jerome Powell's
Incyte to Report Second Quarter Financial Results
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its second quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, July 30, 202
Express News | Incyte Corp : RBC Raises Target Price to $61 From $60
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Incyte (NASDAQ:INCY) today announced that it granted restricted stock unit awards (RSUs) representing an aggregate of 14,577 shares of the Company's common stock and stock option awards to purchase an aggregate of
Notable Analyst Calls This Week: Nvidia, Spirit Airlines and PayPal Among Top Picks
Express News | Incyte Corp - on June 28, Co, Unit Entered Amendment No. 2 to Revolving Credit and Guaranty Agreement Dated as of August 21, 2021
Express News | Incyte Corp - Extended the Maturity Date of the Revolving Credit Facility Under the Existing Credit Agreement From August 18, 2024 to June 28, 2027
S&P 500, Nasdaq Close at Record Highs After Fed Chair Powell's Comments
The S&P 500 and the Nasdaq Composite closed at record highs Tuesday after Federal Reserve Chair Jerome Powell said policymakers have made "quite a bit of progress" against inflation. The tech-heavy Na
Sector Update: Health Care Stocks Retreat Tuesday Afternoon
Health care stocks were declining Tuesday afternoon, with the NYSE Health Care Index shedding 0.8% and the Health Care Select Sector SPDR Fund (XLV) down 0.7%. The iShares Biotechnology ETF (IBB) fell
This CrowdStrike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag